Search results for "thyroid carcinoma"

showing 10 items of 69 documents

Hashimoto Thyroiditis Coexistent with Papillary Thyroid Carcinoma

2005

Several studies report a higher rate of papillary thyroid carcinomas (PTC) in patients with Hashimoto thyroiditis (HT), indicating a possible correlation between the two diseases. We studied a group of 89 subjects undergoing surgery for thyroid carcinomas compared with a control group of 89 subjects operated on for normofunctioning goiter, and a second group of 47 patients undergoing total thyroidectomy for HT. Association with HT was found in 19 of the 71 PTC subjects (26.7%) and in 8 goiter patients (8.9%), which was a significant difference ( P < 0.02). Thirteen of the HT patients, mostly with the nodular form, showed coexistent PTC (27.6%). HT and PTC coexisted in several morphologi…

AdultMaleendocrine systemmedicine.medical_specialtyPathologyGoiterthyroid tumorendocrine system diseasesretrospective studymedicine.medical_treatmentHashimoto Diseasethyroidectomy MeSH: Adenocarcinoma PapillaryGastroenterologyThyroid carcinomaRetrospective StudieInternal medicinemedicineHumanshumanThyroid NeoplasmsThyroid cancerThyroid NeoplasmAgedRetrospective StudiesAutoimmune diseaseadenocarcinoma; adult; aged; article; female; Hashimoto disease; human; male; middle aged; retrospective study; thyroid tumor; thyroidectomy Adenocarcinoma Papillary; Adult; Aged; Female; Hashimoto Disease; Humans; Male; Middle Aged; Retrospective Studies; Thyroid Neoplasms; Thyroidectomy [EMTREE medical terms]business.industryarticleThyroidectomyGeneral MedicineMiddle Agedmedicine.diseaseMajor duodenal papillaAdenocarcinoma PapillaryThyroidectomyImmunohistochemistryAdenocarcinomaFemalebusinessEMTREE medical terms: adenocarcinomaThe American Surgeon
researchProduct

Results of the Thyroid Cancer Alliance international patient/survivor survey: Psychosocial/informational support needs, treatment side effects and in…

2013

To comprehensively assess the experience of a large, diverse cohort and identify potential care improvements, the Thyroid Cancer Alliance, an international patient/survivor group coalition, surveyed thyroid cancer patients/survivors worldwide.English, German, French or Spanish versions of a self-developed 43-item questionnaire were completed, predominantly online, by 2398 respondents from the US (37.9%), Germany (21.3%), the UK (11.5%), Canada (11.4%), France (9%), and 35 other countries. Females and differentiated thyroid carcinoma patients each comprised ~87% of respondents. Diagnosis occurred at age 30-59 years in 71.8%, within1 (1-5) year(s) before survey completion in 16.4% (55%).At di…

AdultMalemedicine.medical_specialtyCanadaReferralCross-sectional studyEndocrinology Diabetes and MetabolismThyroid carcinomaCohort StudiesIodine RadioisotopesSocial supportGermanySurveys and QuestionnairesmedicineHumansSurvivorsThyroid NeoplasmsThyroid cancerReferral and Consultationbusiness.industrySocial SupportGeneral MedicineMiddle Agedmedicine.diseaseUnited KingdomUnited StatesCross-Sectional StudiesFamily medicineCohortThyroidectomyFemaleFrancebusinessPsychosocialStress PsychologicalCohort studyHormones (Athens, Greece)
researchProduct

Papillary Thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries

2013

Papillary thyroid microcarcinoma (PTMC) is an indolent neoplasia, often asymptomatic and discovered incidentally. Some PTMCs, however, exhibit a more aggressive behavior, frequently recur, and can even cause cancer-related death.The aim of this study was to evaluate the prevalence of PTMCs and the associated risk factors at presentation in 2 thyroid cancer registries from areas with different genetic and environmental characteristics.We conducted a retrospective, observational study of all incident cases of PTMCs recorded over a 5-year period in the Sicilian Regional Registry for Thyroid Cancer (SRRTC) and in the Surveillance Epidemiology and End Results (SEER) US registry.The study took pl…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismClinical BiochemistryContext (language use)BiochemistrySettore MED/13 - EndocrinologiaThyroid carcinomaThyroid carcinomaEndocrinologyRisk FactorsPapillary thyroid microcarcinomasInternal medicinemedicineSurveillance Epidemiology and End ResultsHumansCancer registriesRegistriesThyroid NeoplasmsRisk factorSicilyThyroid cancerAgedRetrospective StudiesIncidental FindingsCancer Death Ratebusiness.industryIncidenceIncidence (epidemiology)CarcinomaBiochemistry (medical)Retrospective cohort studyMiddle Agedmedicine.diseaseCarcinoma PapillaryUnited StatesTumor BurdenEndocrinologyThyroid carcinoma; Cancer registriesThyroid Cancer PapillaryFemalebusinessSEER Program
researchProduct

Association between Hashimoto's thyroiditis and papillary thyroid carcinoma: A retrospective analysis of 305 patients

2019

Abstract Background The association between Hashimoto’s thyroiditis (HT) and papillary thyroid carcinoma (PTC) is a controversial question that is still under debate, its pathological significance and the eventual clinical implications of this association remaining unclear. Methods The data regarding 305 patients were retrospectively analyzed. The patients were divided in two different groups. A first group made up of 142 patients undergoing surgery for differentiated thyroid carcinoma was compared to a control group of 142 analogous subjects operated for normofunctioning goiter. A second group was made up of 163 patients who had undergone total thyroidectomy (TT) with pre-operative diagnos…

AdultMalemedicine.medical_specialtyGoiterendocrine system diseasesAdolescentPrognosiEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismHashimoto DiseaseGastroenterologylcsh:Diseases of the endocrine glands. Clinical endocrinologyThyroiditisFollow-Up StudieThyroid carcinoma03 medical and health sciencesYoung Adult0302 clinical medicineHashimoto's thyroiditiRetrospective StudieInternal medicineDiabetes mellitusmedicineRetrospective analysisHumans030212 general & internal medicineThyroid NeoplasmsPathologicalThyroid NeoplasmAgedRetrospective StudiesAged 80 and overlcsh:RC648-665business.industryResearchSignificant differenceGeneral MedicineHashimoto’s thyroiditisMiddle Agedmedicine.diseasePrognosisNodular lesionsThyroid Cancer PapillaryPapillary thyroid carcinomaFemalebusinessHumanFollow-Up Studies
researchProduct

Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy

2017

Abstract Background: To assess the long-term prognostic value of 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in patients with differentiated thyroid carcinoma (DTC) undergoing empiric radioiodine (RAI) therapy due to raising values of thyroglobulin (Tg). Methods: Forty-nine patients with histological diagnosis of DTC (31 with papillary and 18 with follicular carcinoma) follow-up for a mean period of 7.9 ± 5 years after empiric RAI therapy were retrospectively analyzed. Results: FDG-PET/CT was negative in 15 (30.6%) patients and positive in 34 (69.4%), whereas postradioiodine therapy whole body scan (t-WBS) was negative in 16 (32.7%) and positive in…

AdultMalemedicine.medical_specialtymedicine.medical_treatment18F-FDG-PET/CTchemistry.chemical_elementIodinethyroglobulinDiagnostic Accuracy StudyDisease-Free Survival030218 nuclear medicine & medical imagingThyroid carcinomaIodine Radioisotopes03 medical and health sciences0302 clinical medicineFluorodeoxyglucose F18Positron Emission Tomography Computed TomographymedicineHumansThyroid NeoplasmsThyroid cancerdifferentiated thyroid carcinomaAgedRetrospective Studies18F-FDG-PET/CT differentiated thyroid carcinoma empiric therapy prognosis thyroglobulin4300medicine.diagnostic_testbusiness.industryRetrospective cohort studyempiric therapyGeneral MedicineMiddle Agedmedicine.diseasechemistryPositron emission tomography030220 oncology & carcinogenesisF-18-FDG-PETHistopathologyThyroglobulinFemaleRadiologyprognosisRadiopharmaceuticalsNuclear medicinebusinessEmpiric therapyCTResearch Article
researchProduct

Dose-dependent expression of CLIP2 in post-Chernobyl papillary thyroid carcinomas

2015

Summary This study showed a clear dose-response relationship for the CLIP2 radiation marker in post-Chernobyl papillary thyroid carcinoma cohorts for young patients and hints to different molecular mechanisms in tumors induced at low doses compared to moderate/high doses.

AdultOncologyendocrine systemCancer Researchmedicine.medical_specialtyPathologyNeoplasms Radiation-InducedAdolescentendocrine system diseasesOriginal ManuscriptCohort StudiesIodine RadioisotopesThyroid carcinomaYoung Adult03 medical and health sciences0302 clinical medicineInternal medicineBiomarkers TumormedicineCarcinomaHumansThyroid NeoplasmsTypingYoung adultChildThyroid cancer030304 developmental biology0303 health sciencesbusiness.industryCarcinomaThyroidDose-Response Relationship RadiationGeneral Medicinemedicine.diseaseCarcinoma Papillaryhumanities3. Good healthLogistic Modelsmedicine.anatomical_structureChernobyl Nuclear AccidentThyroid Cancer PapillaryChild Preschool030220 oncology & carcinogenesisCohortbusinessMicrotubule-Associated ProteinsCohort studyCarcinogenesis
researchProduct

Molecular characterization of cancer stem cells in anaplastic thyroid carcinoma

2009

Anaplastic thyroid carcinoma stem cellSettore MED/06 - Oncologia MedicaSettore MED/13 - Endocrinologia
researchProduct

Induction of annexin-1 during TRAIL-induced apoptosis in thyroid carcinoma cells

2005

We investigated the expression of annexin-1 (ANXA1) in thyroid carcinoma cell lines and in thyroid cancers with a different degree of differentiation. The highest level of ANXA1 expression examined by Western blotting was detected in the papillary carcinoma cells (NPA) and in the follicular cells (WRO). On the other hand, the most undifferentiated thyroid carcinoma cells (ARO and FRO) presented the lowest level of ANXA1 expression. In surgical tissue specimens from 32 patients with thyroid cancers, we found high immunoreactivity for ANXA1 in papillary (PTC) and follicular (FTC) thyroid cancers while in undifferentiated thyroid cancers (UTC) the expression of the protein was barely detectabl…

ApoptosisTNF-Related Apoptosis-Inducing LigandApoptosis Regulatory ProteinsthyroidThyroid carcinomaTNF-Related Apoptosis-Inducing LigandText miningAnnexinMedicineHumansThyroid NeoplasmsMolecular BiologyThyroid NeoplasmAnnexin A1Apoptosis Regulatory ProteinMembrane Glycoproteinsbusiness.industryTumor Necrosis Factor-alphaApoptosiCell BiologyApoptosisCancer researchMembrane GlycoproteinbusinessApoptosis Regulatory ProteinsHuman
researchProduct

Anaplastic Thyroid Carcinoma: A ceRNA Analysis Pointed to a Crosstalk between SOX2, TP53, and microRNA Biogenesis.

2014

It has been suggested that cancer stem cells (CSC) may play a central role in oncogenesis, especially in undifferentiated tumours. Anaplastic thyroid carcinoma (ATC) has characteristics suggestive of a tumour enriched in CSC. Previous studies suggested that the stem cell factorSOX2has a preeminent hierarchical role in determining the characteristics of stem cells in SW1736 ATC cell line. In detail, silencing SOX2 in SW1736 is able to suppress the expression of the stem markers analysed, strongly sensitizing the line to treatment with chemotherapeutic agents. Therefore, in order to further investigate the role of SOX2 in ATC, a competing endogenous RNA (ceRNA) analysis was conducted in order…

Article SubjectEndocrinology Diabetes and MetabolismSOX2Stem cell factorAnaplastic Thyroid carcinomaBiologyBioinformaticsmedicine.disease_causelcsh:Diseases of the endocrine glands. Clinical endocrinologySettore MED/13 - EndocrinologiaEndocrinologySOX2Cancer stem cellmicroRNAmedicineGene silencinglcsh:RC648-665microRNAEndocrine and Autonomic SystemsCompeting endogenous RNAceRNACancer researchStem cellCarcinogenesisResearch ArticleInternational journal of endocrinology
researchProduct

Detection of BRAFv600E mutation in papillary thyroid carcinoma using real time allele-specific amplification on fine needle aspiration biopsy specime…

2006

BRAF papillary thyroid carcinomaSettore MED/13 - Endocrinologia
researchProduct